Abstract
Acute myeloid leukemia is an aggressive hematologic malignancy with high incidence in adults and poor prognosis, especially in elderly patients. Standard therapy, based on chemotherapy and bone marrow transplantation, is associated with significant toxicity and high relapse rates. Immunotherapy with CAR-T cells has revolutionized the treatment of hematologic neoplasms, such as acute lymph…